797 filings
Page 2 of 40
POS AM
LEXX
Lexaria Bioscience Corp
24 Jan 24
Prospectus update (post-effective amendment)
1:33pm
S-8
LEXX
Lexaria Bioscience Corp
18 Jan 24
Registration of securities for employees
2:38pm
10-Q
2023 Q1
LEXX
Lexaria Bioscience Corp
Quarterly report
12 Jan 24
5:11pm
8-K
LEXX
Lexaria Bioscience Corp
4 Jan 24
Lexaria’s Patented Technology Improved the Oral Performance of the Rybelsus®-Branded GLP-1 drug Semaglutide
5:07pm
EFFECT
LEXX
Lexaria Bioscience Corp
11 Dec 23
Notice of effectiveness
12:15am
424B3
LEXX
Lexaria Bioscience Corp
8 Dec 23
Prospectus supplement
4:31pm
CORRESP
LEXX
Lexaria Bioscience Corp
6 Dec 23
Correspondence with SEC
12:00am
UPLOAD
LEXX
Lexaria Bioscience Corp
6 Dec 23
Letter from SEC
12:00am
S-1
LEXX
Lexaria Bioscience Corp
IPO registration
30 Nov 23
4:14pm
10-K
2023 FY
LEXX
Lexaria Bioscience Corp
Annual report
20 Nov 23
5:16pm
8-K
LEXX
Lexaria Bioscience Corp
3 Nov 23
Other Events
1:13pm
4
Vanessa Carle
1 Nov 23
Lexaria Bioscience / Vanessa Carle ownership change
1:45pm
4
LEXX
Lexaria Bioscience Corp
30 Oct 23
Lexaria Bioscience / JOHN MARTIN DOCHERTY ownership change
12:47pm
4
LEXX
Lexaria Bioscience Corp
30 Oct 23
Lexaria Bioscience / CHRISTOPHER BUNKA ownership change
12:30pm
8-K
LEXX
Lexaria Bioscience Corp
18 Oct 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:25pm
8-K
LEXX
Lexaria Bioscience Corp
16 Oct 23
Lexaria Enters New Global Exclusive Collaboration and License Agreement with SulfoSyn
1:13pm
8-K
LEXX
Lexaria Bioscience Corp
12 Oct 23
Lexaria Granted Two New Patents in Canada
3:57pm
D
LEXX
Lexaria Bioscience Corp
4 Oct 23
$1.57 mm in options, sold $1.57 mm, 1 investor
12:34pm
8-K
LEXX
Lexaria Bioscience Corp
3 Oct 23
Entry into a Material Definitive Agreement
4:05pm
424B5
LEXX
Lexaria Bioscience Corp
2 Oct 23
Prospectus supplement for primary offering
4:06pm